Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farhad Shahram

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Vascular Health and Risk Management|April 2, 2009
Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritisNaheed Aryaeian, Farhad Shahram, Mahmoud Djalali, et al.
Journal of Bone and Mineral Metabolism|April 21, 2007
Intragenic SNP haplotypes associated with 84dup18 mutation in TNFRSF11A in four FEO pedigrees suggest three independent origins for this mutationElahe Elahi, Yousef Shafaghati, Sareh Asadi, et al.
Clinical Rheumatology|September 22, 2010
Gender influence on ocular manifestations and their outcome in Behcet's Disease. A long-term follow-up of up to 20 yearsFereydoun Davatchi, Farhad Shahram, Hormoz Shams, et al.
International Journal of Rheumatic Diseases|August 14, 2010
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study)Fereydoun Davatchi, Hormoz Shams, Mozhgan Rezaipoor, et al.
International Journal of Rheumatology|June 16, 2012
Fc-Gamma Receptor 3B Copy Number Variation Is Not a Risk Factor for Behçet's DiseaseRachel Black, Sue Lester, Emma Dunstan, et al.
Reumatologia|December 5, 2025
Clinical features and chronology of clinical manifestations in Behçet's disease: a cohort of 2,615 patientsShokufe Sadeghi, Seyedeh Tahereh Faezi, Mohammad Nejadhosseinian, et al.
International Journal of Rheumatic Diseases|January 5, 2011
Systemic lupus erythematosus in Iran: a study of 2280 patients over 33 yearsMahmood Akbarian, Seyedeh Tahereh Faezi, Farhad Gharibdoost, et al.
International Journal of Rheumatic Diseases|April 9, 2010
Validation of the International Criteria for Behçet's disease (ICBD) in IranFereydoun Davatchi, Bahar Sadeghi Abdollahi, Farhad Shahram, et al.
Plos One|February 6, 2020
ERAP1 polymorphisms interactions and their association with Behçet's disease susceptibly: Application of Model-Based Multifactor Dimension Reduction Algorithm (MB-MDR)Parisa Riahi, Anoshirvan Kazemnejad, Shayan Mostafaei, et al.
International Journal of Rheumatic Diseases|January 5, 2011
Behcet's disease in Iran: analysis of 6500 casesFereydoun Davatchi, Farhad Shahram, Cheyda Chams-Davatchi, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Vascular Health and Risk Management|April 2, 2009
Effect of conjugated linoleic acid, vitamin E and their combination on lipid profiles and blood pressure of Iranian adults with active rheumatoid arthritisNaheed Aryaeian, Farhad Shahram, Mahmoud Djalali, et al.
Journal of Bone and Mineral Metabolism|April 21, 2007
Intragenic SNP haplotypes associated with 84dup18 mutation in TNFRSF11A in four FEO pedigrees suggest three independent origins for this mutationElahe Elahi, Yousef Shafaghati, Sareh Asadi, et al.
Clinical Rheumatology|September 22, 2010
Gender influence on ocular manifestations and their outcome in Behcet's Disease. A long-term follow-up of up to 20 yearsFereydoun Davatchi, Farhad Shahram, Hormoz Shams, et al.
International Journal of Rheumatic Diseases|August 14, 2010
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study)Fereydoun Davatchi, Hormoz Shams, Mozhgan Rezaipoor, et al.
International Journal of Rheumatology|June 16, 2012
Fc-Gamma Receptor 3B Copy Number Variation Is Not a Risk Factor for Behçet's DiseaseRachel Black, Sue Lester, Emma Dunstan, et al.
Reumatologia|December 5, 2025
Clinical features and chronology of clinical manifestations in Behçet's disease: a cohort of 2,615 patientsShokufe Sadeghi, Seyedeh Tahereh Faezi, Mohammad Nejadhosseinian, et al.
International Journal of Rheumatic Diseases|January 5, 2011
Systemic lupus erythematosus in Iran: a study of 2280 patients over 33 yearsMahmood Akbarian, Seyedeh Tahereh Faezi, Farhad Gharibdoost, et al.
International Journal of Rheumatic Diseases|April 9, 2010
Validation of the International Criteria for Behçet's disease (ICBD) in IranFereydoun Davatchi, Bahar Sadeghi Abdollahi, Farhad Shahram, et al.
Plos One|February 6, 2020
ERAP1 polymorphisms interactions and their association with Behçet's disease susceptibly: Application of Model-Based Multifactor Dimension Reduction Algorithm (MB-MDR)Parisa Riahi, Anoshirvan Kazemnejad, Shayan Mostafaei, et al.
International Journal of Rheumatic Diseases|January 5, 2011
Behcet's disease in Iran: analysis of 6500 casesFereydoun Davatchi, Farhad Shahram, Cheyda Chams-Davatchi, et al.
Pageof 10